#MedicalTechnology

A recent breakthrough by international researchers has led to the development of an ultra-small brain sensor capable of achieving up to 96% accuracy in monitoring neural activity—a leap that could dramatically change the way neurological conditions are diagnosed and treated. The new device, as detailed in ExtremeTech’s report, promises minimally invasive, high-precision monitoring that could one day be seen in Thai medical centers and research institutions.

For Thailand, a nation with a rapidly aging population and increasing cases of neurological disorders such as Alzheimer’s, Parkinson’s, and stroke, this innovation is of keen interest. Presently, neurological disorders impose a substantial burden on Thai families and the healthcare system, where early detection and continuous monitoring are heavily dependent on costly, infrequent, and often physically taxing procedures. The prospect of ultra-miniaturized, highly accurate sensors opens up the potential for safer, more comfortable, and more frequent brain monitoring, possibly even from home.

A major new study has raised eyebrows around the world by suggesting that up to 5% of all cancers may be linked to the use of computed tomography (CT) scans—a powerful and commonly used medical imaging tool. While these results have set off alarm bells among patients and healthcare providers, leading experts caution that the numbers come with significant uncertainties. The findings, first reported by Ars Technica, have triggered fresh debate about the delicate balance between medical necessity and risk, shining a spotlight on how medical technology shapes health outcomes in Thailand and globally.